Diagnostic Utility of Splenial Lesions in a Case of Legionnaires' Disease due to <i>Legionella pneumophila</i> Serogroup 2
-
- Tomizawa Yuji
- Department of Neurology, Juntendo University Shizuoka Hospital, Japan
-
- Hoshino Yasunobu
- Department of Neurology, Juntendo University, School of Medicine, Japan
-
- Sasaki Fuyuko
- Department of Neurology, Juntendo University, School of Medicine, Japan
-
- Kurita Naohide
- Department of Neurology, Juntendo University, School of Medicine, Japan
-
- Kawajiri Sumihiro
- Department of Neurology, Juntendo University Shizuoka Hospital, Japan
-
- Noda Kazuyuki
- Department of Neurology, Juntendo University Shizuoka Hospital, Japan
-
- Hattori Nobutaka
- Department of Neurology, Juntendo University, School of Medicine, Japan
-
- Amemura-Maekawa Junko
- Department of Bacteriology I, National Institute of Infectious Diseases, Japan
-
- Kura Fumiaki
- Department of Bacteriology I, National Institute of Infectious Diseases, Japan
-
- Okuma Yasuyuki
- Department of Neurology, Juntendo University Shizuoka Hospital, Japan
この論文をさがす
抄録
We herein report the case of a 49-year-old man with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) associated with Legionnaires' disease due to Legionella pneumophila serogroup 2. Past reports suggest that Legionella infection is frequent in cases of MERS-associated pneumonia. Obtaining an early diagnosis of legionella infection is a challenge, especially if a Legionella pneumophila serogroup other than serogroup 1 contains the causative agent. In this case, the splenial lesion played an important role in recognizing the legionella infection. We suggest that legionella infection should be considered as a differential diagnosis in cases of splenial lesions associated with pneumonia.<br>
収録刊行物
-
- Internal Medicine
-
Internal Medicine 54 (23), 3079-3082, 2015
一般社団法人 日本内科学会